High Tech Campus 32
Full-time employees: 96
|Mr. David L. Marver||CEO & Director||961k||N/A||1968|
|Mr. Gregoire Courtine Ph.D.||Chief Scientific Officer & Director||N/A||N/A||1975|
|Ms. Lara Smith Weber||Chief Financial Officer||N/A||N/A||N/A|
|Mr. Robert W. Odell||VP of Operations||N/A||N/A||1960|
|Mr. John Murphy||Chief Technology Officer||N/A||N/A||N/A|
|Mr. Andy Dolan||VP of Sales||N/A||N/A||N/A|
|Sarah Moore||VP of Global Marketing||N/A||N/A||N/A|
|Ms. Rano Burkhanova||Global HR Director||N/A||N/A||N/A|
Onward Medical N.V., a medical technology company, focuses on developing therapies for spinal cord injuries in the Netherlands and internationally. The company engages in developing ARC-EX, an external non-invasive platform that consists of a wearable stimulator and wireless programmer; and ARCIM, an implantable platform, which consists of an implantable pulse generator and lead that is placed near the spinal cord. It also engages in developing Up-LIFT Trial to evaluate the safety and effectiveness of non-invasive electrical spinal cord stimulation to treat upper extremity functional deficits with chronic tetraplegia. The company was founded in 2014 and is headquartered in Eindhoven, Netherlands.
Onward Medical N.V.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.